Join Us for the Bayer Expert Monday Series!
Attention Innovators and Early Stage Entrepreneurs!
Bayer is excited to host the 2025 Bayer Expert Monday series, designed specifically for innovative minds in the life sciences. This virtual series provides you with exclusive access to Bayer experts who will share their invaluable insights, experiences, and guidance to help you navigate the complexities of pharmaceutical development.
If you are an early stage entrepreneur, work with startups, or interested in advancing your knowledge in pharmaceutical development, particularly in oncology, cell and gene therapy, cardiovascular/renal, and immunology, secure your spot and register today! Don’t miss this opportunity to learn from the best and elevate your entrepreneurial journey! We look forward to seeing you at our first session and supporting your mission to innovate in the pharmaceutical industry!
What to Expect:
- Expert Insights: Each session will feature a leading expert from Bayer, covering a range of topics including drug discovery, regulatory pathways, clinical trials, and commercialization strategies, with a focus on our strategic areas of interest: oncology, cell and gene therapy, cardiovascular/renal, and immunology.
- Interactive Q&A: Engage directly with our experts during live Q&A sessions, allowing you to ask your most pressing questions and gain tailored advice for your entrepreneurial journey.
- Networking Opportunities: Connect with fellow early stage entrepreneurs and build valuable relationships within the pharmaceutical community.
Session topic: Capital Connect: What Attracts VCs, Investment Banks, and Pharma Investors
Join Rakhshita Dhar to explore key factors that drive investment decisions in biotech and pharma and how companies can position themselves for success in an evolving financial landscape!
Rakhshita Dhar
Venture Investments, Pharma
Leaps by Bayer
Rakhshita Dhar is Senior Director of Venture Investments Health at Leaps by Bayer. She joined the team in 2021 and is responsible for search & evaluation and healthcare focused investment for Leaps. She currently sits on the board of Deka Biosciences, Gro Bio, and Edifice Health.
Prior to joining Leaps, Rakhshita was Director of Business Development at Roche Pharmaceuticals where she led collaborations with Dyno Therapeutics and Rheos Biosciences. She also spent a few years at MassBio developing an accelerator program for life-science start-ups.
She got her Undergraduate degree in Biochemistry from Mumbai University and her Masters in Molecular Biology from Georgetown University.
What you need to know:
- Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts.
- These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey.
- Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.
- Each session has a maximum capacity of 500 participants.
Interested in hearing from more experts? Register today for the next session!
Click here to register for the next session in the Bayer Expert Monday Series. Join Matteo Aldeghi, Senior Director of Machine Learning at Bayer and Gurpreet Singh, Senior Director of Applied Machine Learning at Bayer for Strategic Interest in External Innovation: Data Science.